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extracranial carotid stent placement: A
nationwide self-controlled case-series study”To the Editor,
We would like to thank Dr Kao and colleagues for raising
several important issues and commenting on our article
concerning the effectiveness and safety of extracranial
carotid stent placement.1 In this report, we identified pa-
tients who underwent carotid artery stenting (CAS) be-
tween 2005 and 2008 from Taiwan’s National Health
Insurance database, and performed a self-controlled case
series analysis. The results showed that the use of statin
was associated with a reduced risk of ischemic stroke in the
1st month, while CAS performed by low-volume operators
was associated with a twofold increased risk. CAS also
reduced the long-term risk for ischemic stroke.
It was challenging to identify the eligible patients from
the National Health Insurance claims database when many
crucial clinical data, such as cerebrovascular symptoms,
blood tests, carotid echo and angiographic findings, brain
imaging, and technical information, were not available.
Thus, the strategy in patient selection was to improve the
positive predictive value for identifying “real” cases through
the following two steps: (1) to maximize the “recall” (i.e.,
including all possible patients) and then (2) to improve the
“precision” (i.e., by excluding any not-so-sure patients).
Concerning the recall issue, the statement of “nine
different types of stents” might be incorrect, and only six
stents have been approved for carotid indication in Taiwan
by the Department of Health. However, since these stents
might have different names, sizes, and even codes at
different time points, we must include all of them to in-
crease the recall rate. On the contrary, patients who paid
for their CAS procedure themselves could not be identified.
We excluded the patients who received CAS more than
once and who had atrial fibrillation to improve the precisionConflicts of interest: The authors have no conflicts of interest
relevant to this article.
http://dx.doi.org/10.1016/j.jfma.2015.01.014
0929-6646/Copyright ª 2015, Formosan Medical Association. Publishedof patient selection. Since it was difficult to find a suitable
control group, we compared the post-stent risk in different
time periods with the prestent risk in a time-dependent
manner. Patients who received CAS more than once could
not fit to this model. Moreover, patients with atrial fibril-
lation might have different risk profiles and were also
excluded. These efforts to improve precision would inevi-
tably exclude some “real” cases from further analysis, i.e.,
there is always a tradeoff between validity and generaliz-
ability. The inclusion/exclusion criteria ensured that the
results were valid, but generalization of the results to other
patient groups could be limited.
It is also pointed out that not all the selected patients
were “the first-time CAS recipients” because some of them
might have received CAS prior to 2004. To avoid this prob-
lem, we allowed a 1-year period between cohort initiation
(2004) and patient selection (2005), i.e., the patients who
underwent CAS in 2004 were not included. This could
largely reduce the possibility of “not the first-time CAS.”
More importantly, the time gap provided a full 365-day
period to estimate the prestent baseline risk.
We reported a total of 1487 patients, aged  20 years,
undergoing extracranial CAS between 2005 and 2008.
Among them, 37% had diabetes. The description on top of
Fig. 1 “Diabetic patients age 20 years had ever received
carotid artery stenting in 2005e2008 (N Z 1487)” is a
typographical error, and the correction has been made
(new Figure 1). We appreciate the suggestions and com-
ments from Dr Kao and colleagues. These carotid
interventionists should have been invited for participation
in hope of a better understanding of this valuable database.
We believe that the results regarding the beneficial effects
of preoperative statin use, lower risk associated with high-
volume operators, and time-dependent postoperative risk
reduction are still valid, and the clinical implications
remain unchanged.by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Study flow.
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